• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD SYRINGE 30ML LL TIP CONV PAK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD SYRINGE 30ML LL TIP CONV PAK Back to Search Results
Catalog Number 305618
Medical Device Problem Code Device Contamination with Chemical or Other Material (2944)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/27/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd syringe 30ml ll tip conv pak had foreign matter the following information was provided by the initial reporter: it was reported by customer that cardboard debris was observed in the barrel of a syringe and as well in tray.Verbatim: cardboard debris was observed in the barrel of a syringe.Cardboard debris was observed in the tray.
 
Event or Problem Description
N/a.
 
Additional Manufacturer Narrative
Our quality engineer inspected the 17 pictures, 3 sample trays and 2 syringes submitted for evaluation.The reported issue of foreign matter was confirmed upon inspection of the samples and photos.Analysis of the tray samples and photos showed that there was cardboard within the trays.No foreign matter was observed within the syringes.Bd determined that the cause of the failure was associated to incorrect handling of materials during the packaging process.A retraining of the manufacturing personnel involved in the packaging process has been performed to help prevent the recurrence of this failure mode.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.Production records were reviewed, and this batch meets our manufacturing specification requirements.We appreciate you taking the time to bring this observation to our attention.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.We regret any inconveniences this incident may have caused you and your facility.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD SYRINGE 30ML LL TIP CONV PAK
Common Device Name
SYRINGE
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19038997
Report Number9610847-2024-00080
Device Sequence Number8471572
Product Code FMF
UDI-Device Identifier30382903056188
UDI-Public(01)30382903056188
Combination Product (Y/N)N
Initial Reporter StateCT
Initial Reporter CountryUS
PMA/510(K) Number
K110771
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/08/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number305618
Device Lot Number3212633
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/12/2024
Supplement Date Received by Manufacturer04/29/2024
Initial Report FDA Received Date04/03/2024
Supplement Report FDA Received Date05/09/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/29/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-